ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BlueRock, Sloan Kettering Receive IND Clearance for DA01 for Parkinson’s Disease
January 14, 2021BlueRock Therapeutics, a wholly-owned subsidiary of Bayer AG, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), announced the U.S. Food and Drug Administration (FDA) has cleared their Investigational New Drug (IND) application to ...
Pharma Sources Insight January 2025
